The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis

키워드

참고문헌 (55)

1. Hellman S, "Oligometastases", J Clin Oncol, 13, pp.8~10 (1995)
2. Hughes KS, "Resection of the liver for colorectal carcinoma metastases : a multi-institutional study of long-term survivors", Dis Colon Rectum, 31, pp.1~4 (1988)
3. Nordlinger B, "Surgical resection of colorectal carcinoma metastases to the liver : a prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie", Cancer, 77, pp.1254~1262 (1996)
4. Weichselbaum RR, "Oligometastases revisited", Nat Rev Clin Oncol, 8, pp.378~382 (2011)
5. Gomez DR, "Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer : long-term results of a multi-institutional, phase II, randomized study", J Clin Oncol, 37, pp.1558~1565 (2019)
6. Iyengar P, "Consolidative radiotherapy for limited metastatic non-small-cell lung cancer : a phase 2 randomized clinical trial", JAMA Oncol, 4, pp.e173501~ (2018)
7. Parker CC, "Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer(STAMPEDE) : a randomised controlled phase 3 trial", Lancet, 392, pp.2353~2366 (2018)
8. Biasco G, "Treatment of hepatic metastases from colorectal cancer : many doubts, some certainties", Cancer Treat Rev, 32, pp.214~228 (2006)
9. Van Cutsem E, "Towards a pan-European consensus on the treatment of patients with colorectal liver metastases", Eur J Cancer, 42, pp.2212~2221 (2006)
10. Grossmann I, "Preoperative staging with chest CT in patients with colorectal carcinoma : not as a routine procedure", Ann Surg Oncol, 17, pp.2045~2050 (2010)
11. Qiu M, "Pattern of distant metastases in colorectal cancer : a SEER based study", Oncotarget, 6, pp.38658~38666 (2015)
12. Vatandoust S, "Colorectal cancer : metastases to a single organ", World J Gastroenterol, 21, pp.11767~11776 (2015)
13. Ruers T, "Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in pati-ents with non-resectable colorectal liver metastases : a randomized EORTC Intergroup phase II study(EORTC 40004)", Ann Oncol, 23, pp.2619~2626 (2012)
14. Treasure T, "Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer(PulMiCC) : a multicentre randomised clinical trial", Trials, 20, pp.718~ (2019)
15. Lee BM, "Importance of local ablative therapies for lung metastases in patients with colorectal cancer", Ann Surg, 278, pp.e173~e178 (2023)
16. Willmann J, "Repeat stereotactic body radio-therapy for oligometastatic disease", Radiother Oncol, 184, pp.109671~ (2023)
17. Onaitis MW, "Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases", Ann Thorac Surg, 87, pp.1684~1688 (2009)
18. Lee WS, "Pulmonary resection for metastases from colorectal cancer : prognostic factors and survival", Int J Colorectal Dis, 22, pp.699~704 (2007)
19. Okunieff P, "Stereotactic body radiation therapy(SBRT)for lung metastases", Acta Oncol, 45, pp.808~817 (2006)
20. Rusthoven KE, "Multi-institutional phase I", II trial of stereotactic body radiation therapy for liver metastases, 2009, pp.27, 1572~1578
21. "Colon cancer version 4.2023" (2023)[URL]
22. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", Ann Intern Med, 151, pp.264~269 (2009)
23. Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", Eur J Epidemiol, 25, pp.603~605 (2010)
24. Cochran WG, "The combination of estimates from different experiments", Biometrics, 10, pp.101~129 (1954)
25. Higgins JP, "Quantifying heterogeneity in a meta-analysis", Stat Med, 21, pp.1539~1558 (2002)
26. Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
27. Duval S, "Trim and fill : a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis", Biometrics, 56, pp.455~463 (2000)
28. Comito T, "Stereotactic ablative radiotherapy(SABR)in inoperable oligometastatic disease from colorectal cancer : a safe and effective approach", BMC Cancer, 14, pp.619~ (2014)
29. Binkley MS, "Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy", Int J Radiat Oncol Biol Phys, 92, pp.1044~1052 (2015)
30. Carvajal C, "Stereotactic body radiotherapy for colorectal lung oligometastases : preliminary single-institution results", J BUON, 20, pp.158~165 (2015)
31. Jung J, "Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer", Radiat Oncol, 10, pp.238~ (2015)
32. Aoki M, "Stereotactic body radiotherapy for lung metastases as oligo-recurrence : a single institutional study", J Radiat Res, 57, pp.55~61 (2016)
33. Filippi AR, "Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer", Clin Oncol(R Coll Radiol), 28, pp.505~512 (2016)
34. Agolli L, "Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients : outcomes and prognostic factors after long-term follow-up", Clin Colorectal Cancer, 16, pp.58~64 (2017)
35. Jingu K, "Dose escalation improves outcome in stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer", Anticancer Res, 37, pp.2709~2713 (2017)
36. Kinj R, "Radiosensitivity of colon and rectal lung oligometastasis treated with stereotactic ablative radiotherapy", Clin Colorectal Cancer, 16, pp.e211~e220 (2017)
37. Pasqualetti F, "Stereotactic body radiotherapy in patients with lung oligometastases from colorectal cancer", Anticancer Res, 37, pp.315~319 (2017)
38. Qiu H, "Stereotactic body radiotherapy for lung metastases from colorectal cancer : prognostic factors for disease control and survival", Am J Clin Oncol, 41, pp.53~58 (2018)
39. Dell’Acqua V, "Stereotactic radiation therapy in oligometastatic colorectal cancer : outcome of 102 patients and 150 lesions", Clin Exp Metastasis, 36, pp.331~342 (2019)
40. Kalinauskaite GG, "Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases", BMC Cancer, 20, pp.404~ (2020)
41. Nicosia L, "Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy", Strahlenther Onkol, 196, pp.813~820 (2020)
42. Sharma A, "Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy", Radiother Oncol, 144, pp.23~29 (2020)
43. Yamamoto T, "Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma", J Radiat Res, 61, pp.935~944 (2020)
44. Benson KRK, "Local recurrence outcomes of colorectal cancer oligometastases treated with stereotactic ablative radiotherapy", Am J Clin Oncol, 44, pp.559~564 (2021)
45. Nicosia L, "A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer : The LaIT-SABR study", Radiother Oncol, 166, pp.92~99 (2022)
46. Sheikh S, "An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy(SBRT)of oligometastatic colorectal cancer", Radiother Oncol, 167, pp.187~194 (2022)
47. Siebenhuner AR, "Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases", BMC Cancer, 20, pp.246~ (2020)
48. Yu WS, "Pulmonary metastasectomy in colorectal cancer : a population-based retrospective cohort study using the Korean National Health Insurance Database", Cancer Res Treat, 53, pp.1104~1112 (2021)
49. Kuo HT, "Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma", Medicine(Baltimore), 96, pp.e9249~ (2017)
50. Owen D, "Some like it hot : the value of dose and hot spots in lung stereotactic body radiation therapy", Int J Radiat Oncol Biol Phys, 117, pp.1~5 (2023)
51. Klement RJ, "Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases", Radiother Oncol, 123, pp.218~226 (2017)
52. Van den Begin R, "The METABANK score : a clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease", Radiother Oncol, 133, pp.113~119 (2019)
53. Willmann J, "Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy : a retrospective single center study", Radiother Oncol, 168, pp.256~264 (2022)
54. Franzese C, "Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy", J Cancer Res Clin Oncol, 146, pp.1227~1234 (2020)
55. Klement RJ, "Stereotactic body radiotherapy for oligo-metastatic liver disease : influence of pre-treatment chemotherapy and histology on local tumor control", Radiother Oncol, 123, pp.227~233 (2017)

관련 논문AI추천